ArticleJournal of neurodevelopmental disorders2017

A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome.

Andrew Ligsay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.